Search

Marsha de Cordova MP presented with an Honorary Fellowship of The College of Optometrists

This week, The College of Optometrists formally presented Marsha de Cordova MP with an Honorary Fellowship at the College’s headquarters in London. Marsha de Cordova is the Labour MP for Battersea, a former Lambeth Councillor and a longstanding champion of...

Everyday diabetes medicine could treat common cause of blindness

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

Sheraz Daya awarded prestigious IIRSI gold medal for contribution to ophthalmology

Centre for Sight, the UK’s leading and most trusted centre of excellence for advanced eye care, innovation and life-changing results, is proud to announce that its Founder and Medical Director, Sheraz Daya, has been awarded the prestigious IIRSI Gold Medal...

Unlocking the power of simulation: a next generation solution to training ophthalmic professionals

With experts predicting that global blindness will triple by 2050, and the number of people requiring eyecare already outpacing the number of trained ophthalmologists, eyecare training has never been more vital. Traditional in-person ophthalmic training has been curtailed by the...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Oriel celebrates breaking ground milestone

A special breaking ground celebration was held on 11 July to mark the start of construction to build Oriel, a new eyecare, research and education centre in Camden.

Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis

A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation.

World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness

Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.